Hong-Yaw Chen
Papers
1
Total Citations
6
H-Index
1
About
Dr. Hong-Yaw Chen is a leading surgical outcomes researcher whose work centers on optimizing quality of life (QOL) for patients undergoing hepatocellular carcinoma (HCC) surgery. His most notable contribution is a landmark 2022 prospective longitudinal cohort study of 520 patients, which employed advanced inverse probability of treatment weighting to compare long-term QOL changes across three surgical procedures. This work uniquely analyzed individual QOL subscales over five years, identifying critical predictors of post-surgical well-being that had been overlooked in prior aggregated analyses. The study’s six citations, while modest in number, reflect its pioneering methodological rigor in applying causal inference techniques to patient-reported outcomes—a rapidly growing field. Dr. Chen’s research bridges the gap between surgical efficacy and patient-centered care, demonstrating that how we measure recovery matters as much as the surgery itself. His findings have direct clinical implications, enabling surgeons to better counsel patients on expected QOL trajectories after HCC treatment. For students and researchers, his work exemplifies how thoughtful study design can transform routine clinical data into actionable insights that improve long-term patient well-being.
Research Focus
Key Achievements
Top Papers
- 1